Table of Contents
ISRN Obstetrics and Gynecology
Volume 2011, Article ID 457204, 20 pages
http://dx.doi.org/10.5402/2011/457204
Review Article

Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females

Center of Excellence, Women's Health, University of Missouri-Kansas City School of Medicine, 7900 Lee's Summit Road, Kansas City, MO 64139, USA

Received 6 June 2011; Accepted 13 July 2011

Academic Editor: L. C. Zeferino

Copyright © 2011 Diane M. Harper and Stephen L. Vierthaler. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [23 citations]

The following is the list of published articles that have cited the current article.

  • L. Tomljenovic, and C. A. Shaw, “No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil?,” Journal of Internal Medicine, vol. 272, no. 5, pp. 514–515, 2012. View at Publisher · View at Google Scholar
  • Lucija Tomljenovic, and Christopher A. Shaw, “Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine Gardasil,” The Journal of Law, Medicine & Ethics, vol. 40, no. 3, pp. 673–681, 2012. View at Publisher · View at Google Scholar
  • Shalanda A. Bynum, Stephanie A.S. Staras, Teri L. Malo, Anna R. Giuliano, Elizabeth Shenkman, and Susan T. Vadaparampil, “Factors Associated With Medicaid Providers' Recommendation of the HPV Vaccine to Low-Income Adolescent Girls,” Journal of Adolescent Health, 2013. View at Publisher · View at Google Scholar
  • Wojciech Kamzol, Katarzyna Jaglarz, Krzysztof A. Tomaszewski, Miroslawa Puskulluoglu, and Krzysztof Krzemieniecki, “Assessment of knowledge about cervical cancer and its prevention among female students aged 17–26 years,” European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 166, no. 2, pp. 196–203, 2013. View at Publisher · View at Google Scholar
  • Inge Verdenius, Felicia Ratnaraj, Anne M. Arey, Beth Rosemergey, Gerard J. Malnar, and Jeffrey Wall, “Quantifying Clinical HPV4 Dose Inefficiencies in a Safety Net Population,” Plos One, vol. 8, no. 11, 2013. View at Publisher · View at Google Scholar
  • H. W. Nijman, T. A. Westra, J. C. Wilschut, M. J. Postma, J. Luttjeboer, and T. Daemen, “Cost-effectiveness of the prophylactic HPV vaccine: An application to the Netherlands taking non-cervical cancers and cross-protection into account,” Vaccine, vol. 31, no. 37, pp. 3922–3927, 2013. View at Publisher · View at Google Scholar
  • Caterina Ricci, Giovanni Scambia, and Carmine Conte, “HPV vaccine cross-protection: Highlights on additional clinical benefit,” Gynecologic Oncology, vol. 130, no. 3, pp. 642–651, 2013. View at Publisher · View at Google Scholar
  • Markus Stein, Paolo Ruggiero, Rino Rappuoli, and Fabio Bagnoli, “Helicobacter pylori CagA: from pathogen mechanisms to its use as an anti-cancer vaccine,” Frontiers In Immunology, vol. 4, 2013. View at Publisher · View at Google Scholar
  • Geisa Picksius Zardo, Flyvia Peixoto Farah, Fernanda Gabriela Mendes, Camila Ament Giuliani dos Santos Franco, Giseli Vieira Machado Molina, Gislaine Nochetti de Melo, and Solena Ziemer Kusma, “Vaccines as an agent for immunization against HPV,” Ciencia & Saude Coletiva, vol. 19, no. 9, pp. 3799–3808, 2014. View at Publisher · View at Google Scholar
  • Diane M. Harper, “Conclusions About the Quadrivalent Human Papillomavirus Vaccine Efficacy Based on Alternate Dosing Schedules and Less Than Three Dose Immunogenicity is Inappropriate,” Journal of Infectious Diseases, vol. 210, no. 2, pp. 330–+, 2014. View at Publisher · View at Google Scholar
  • Natalie Marya Alexander, Diane Medved Harper, Johanna Claire Comes, Melissa Smith Smith, Melinda Ann Heutinck, Sandra Martin Handley, and Debra Ann Ahern, “Intent to Participate in Future Cervical Cancer Screenings Is Lower when Satisfaction with the Decision to Be Vaccinated Is Neutral,” Plos One, vol. 9, no. 6, 2014. View at Publisher · View at Google Scholar
  • Kelly Jo Sandri, Inge Verdenius, Mitchell J. Bartley, Britney M. Else, Christopher A. Paynter, Beth E. Rosemergey, George D. Harris, Gerard J. Malnar, Sean M. Harper, R. Stephen Griffith, Aaron J. Bonham, and Diane M. Harper, “Urban and Rural Safety Net Health Care System Clinics: No Disparity in HPV4 Vaccine Completion Rates,” Plos One, vol. 9, no. 5, 2014. View at Publisher · View at Google Scholar
  • Christopher B. Fox, Sandra J. Sivananthan, Malcolm S. Duthie, Julie Vergara, Jeffrey A. Guderian, Elliot Moon, David Coblentz, and Steven G. Reed, “A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7,” Journal of Nanobiotechnology, vol. 12, 2014. View at Publisher · View at Google Scholar
  • D. S. LaMontagne, “Reply to Harper,” Journal of Infectious Diseases, 2014. View at Publisher · View at Google Scholar
  • Paolo Pellegrino, Valentina Perrone, Marco Pozzi, Carla Carnovale, Cristiana Perrotta, Emilio Clementi, and Sonia Radice, “The epidemiological profile of ASIA syndrome after HPV vaccination: an evaluation based on the Vaccine Adverse Event Reporting Systems,” Immunologic Research, 2014. View at Publisher · View at Google Scholar
  • Paolo Pellegrino, Carla Carnovale, Marco Pozzi, Stefania Antoniazzi, Valentina Perrone, Dionigi Salvati, Marta Gentili, Tatiana Brusadelli, Emilio Clementi, and Sonia Radice, “On the relationship between human papilloma virus vaccine and autoimmune diseases,” Autoimmunity Reviews, 2014. View at Publisher · View at Google Scholar
  • Remko P. Bosgraaf, Albert G. Siebers, Joanne A. De Hullu, Leon F. A. G. Massuger, Johan Bulten, Ruud L. M. Bekkers, and Willem J. G. Melchers, “The current position and the future perspectives of cervical cancer screening,” Expert Review of Anticancer Therapy, vol. 14, no. 1, pp. 75–92, 2014. View at Publisher · View at Google Scholar
  • Kwang Sung Kim, Shin Ae Park, Kyung-Nam Ko, Seokjae Yi, and Yang Je Cho, “Current status of human papillomavirus vaccines,” Clinical and Experimental Vaccine Research, vol. 3, no. 2, pp. 168, 2014. View at Publisher · View at Google Scholar
  • Paolo Pellegrino, Sonia Radice, and Emilio Clementi, “,” Vaccine, 2015. View at Publisher · View at Google Scholar
  • Yan Liang, Fan-Ya Meng, Hai-Feng Pan, and Dong-Qing Ye, “A literature review on the patients with autoimmune diseases following vaccination against infections,” Human Vaccines & Immunotherapeutics, vol. 11, no. 9, pp. 2274–2280, 2015. View at Publisher · View at Google Scholar
  • Nancy S. Handler, Marc Z. Handler, Slawomir Majewski, and Robert A. Schwartz, “Human papillomavirus vaccine trials and tribulations,” Journal of the American Academy of Dermatology, vol. 73, no. 5, pp. 759–767, 2015. View at Publisher · View at Google Scholar
  • Adebayo J. Molehin, Juan U. Rojo, Sabrina Z. Siddiqui, Sean A. Gray, Darrick Carter, and Afzal A. Siddiqui, “Development of a schistosomiasis vaccine,” Expert Review of Vaccines, pp. 1–9, 2016. View at Publisher · View at Google Scholar
  • Ghazi A. Alsbeih, Najla M. Al-Harbi, Sara S. Bin Judia, Hatim A. Khoja, Mohamed M. Shoukri, and Asma M. Tulbah, “ Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence ,” Cancer, 2017. View at Publisher · View at Google Scholar